Literature DB >> 10673980

Cancer mortality in Europe, 1990-1994, and an overview of trends from 1955 to 1994.

F Levi1, F Lucchini, E Negri, P Boyle, C La Vecchia.   

Abstract

Mortality data, abstracted from the WHO database, are presented in tabular form for 26 cancer sites or groups of sites, plus total cancer mortality, in 35 European countries during the period 1990-1994. Trends in mortality are also given in graphical form for 24 major countries over the period 1955-1994. In most western European countries total cancer mortality was--for the first time--moderately downwards in the early 1990s. Such favourable trends included some decline in lung cancer mortality for males, the persistent decline in stomach cancer for both sexes, and of cervical cancer for women, as well as some decline in breast and colorectal cancers, plus other neoplasms (testis, lymphoid neoplasms), whose treatment has further improved over the last few years. However, cancer mortality was still upwards in a few southern and eastern European countries, including Hungary and Poland, where total cancer mortality rates in middle-aged males are now the highest ever registered in Europe. The favourable trends in western Europe over the recent years are similar to those observed in the U.S.A.

Entities:  

Mesh:

Year:  1999        PMID: 10673980     DOI: 10.1016/s0959-8049(99)00154-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  [Treatment of small-cell lung cancer].

Authors:  M Reck; S Bohnet
Journal:  Internist (Berl)       Date:  2011-02       Impact factor: 0.743

Review 3.  Adjuvant therapy in completely resected non-small-cell lung cancer.

Authors:  Giorgio V Scagliotti; Silvia Novello
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

4.  Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.

Authors:  I Chatzistamou; A V Schally; B Sun; P Armatis; K Szepeshazi
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

Review 5.  Epidemiological trends in digestive cancers in Romania, 1955-2012, compared to alcohol consumption. Correlation or coincidence?

Authors:  Simona Valean; Romeo Chira; Dan Dumitrascu
Journal:  Clujul Med       Date:  2018-10-30

Review 6.  Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4.

Authors:  Freddie Bray; Mathieu Laversanne; Bochen Cao; Cherian Varghese; Bente Mikkelsen; Elisabete Weiderpass; Isabelle Soerjomataram
Journal:  Cancer Treat Rev       Date:  2021-09-09       Impact factor: 12.111

7.  Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature.

Authors:  Lutfiye Demir; Cigdem Erten; Seyran Ceri Yigit; Alper Can; Ahmet Dirican; Vedat Bayoglu; Yuksel Kucukzeybek; Isil Somali; M Oktay Tarhan
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29

8.  Lifetime body mass index and risk of oral cavity and oropharyngeal cancer by smoking and drinking habits.

Authors:  A Nieto; M J Sánchez; C Martínez; X Castellsagué; M J Quintana; X Bosch; M Conde; N Muñoz; R Herrero; S Franceschi
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

9.  Trends in oral cavity, pharyngeal, oesophageal and gastric cancer mortality rates in Spain, 1952-2006: an age-period-cohort analysis.

Authors:  Daniel Seoane-Mato; Nuria Aragonés; Eva Ferreras; Javier García-Pérez; Marta Cervantes-Amat; Pablo Fernández-Navarro; Roberto Pastor-Barriuso; Gonzalo López-Abente
Journal:  BMC Cancer       Date:  2014-04-11       Impact factor: 4.430

10.  Trends in mortality from Hodgkin's disease in western and eastern Europe.

Authors:  F Levi; F Lucchini; E Negri; P Boyle; C La Vecchia
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.